During the past decade, The First Hospital of Jilin University conducted 559 clinical trials. In the 10-year time frame, 559 clinical trials started and 82 clinical trials were completed, i.e. on average, 14.7% percent of trials that started reached the finish line to date. In the past 5 years, 320 clinical trials started and 61 clinical trials were completed. i.e. 19.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Hospital of Jilin University" #1 sponsor was "Hoffmann-La Roche" with 46 trials, followed by "The First Hospital of Jilin University" with 36 trials sponsored, "Sunshine Lake Pharma Co., Ltd." with 22 trials sponsored, "BeiGene" with 20 trials sponsored and "Yi Yang" with 20 trials sponsored. Other sponsors include 478 different institutions and companies that sponsored additional 215 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Hospital of Jilin University" #1 collaborator was "The First Hospital of Jilin University" with 38 trials as a collaborator, "The First Affiliated Hospital with Nanjing Medical University" with 10 trials as a collaborator, "Qilu Hospital of Shandong University" with 9 trials as a collaborator, "Ruijin Hospital" with 9 trials as a collaborator and "The First Affiliated Hospital of Anhui Medical University" with 9 trials as a collaborator. Other collaborators include 937 different institutions and companies that were collaborators in the rest 572 trials.

According to Clinical.Site data, the most researched conditions in "The First Hospital of Jilin University" are "Breast Cancer" (15 trials), "Chronic Hepatitis B" (15 trials), "Hepatitis B, Chronic" (15 trials), "Acute Ischemic Stroke" (12 trials) and "Gastric Cancer" (11 trials). Many other conditions were trialed in "The First Hospital of Jilin University" in a lesser frequency.

Most popular intervention types in "The First Hospital of Jilin University" are "Drug" (482 trials), "Other" (49 trials), "Procedure" (40 trials), "Biological" (34 trials) and "Device" (33 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (104 trials), "placebo" (15 trials), "Atezolizumab" (12 trials), "Tislelizumab" (12 trials) and "Cisplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "The First Hospital of Jilin University" are 577 trials for "All" genders, 30 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 287 active trials in "The First Hospital of Jilin University". 20 are not yet recruiting, 165 are recruiting, 99 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 220 completed trials in The First Hospital of Jilin University, 2 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in The First Hospital of Jilin University, 107 "Phase 1" clinical trials were conducted, 165 "Phase 2" clinical trials and 234 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 26 trials, and there were also 58 trials that are defined as “Not Applicable".